Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Defect Risk Declines for the First Time in Eight Months, According to First American’s Loan Application Defect Index

Published

on

Reading Time: 4 minutes

—The future of fraud and misrepresentation risk is tied closely to
mortgage rates, says Chief Economist Mark Fleming—

SANTA ANA, Calif.–(BUSINESS WIRE)–First
American Financial Corporation
(NYSE: FAF), a leading
global provider of title insurance, settlement services and risk
solutions for real estate transactions, today released the First
American Loan Application Defect Index
for April 2019, which
estimates the frequency of defects, fraudulence and misrepresentation in
the information submitted in mortgage loan applications. The Defect
Index reflects estimated mortgage loan defect rates over time, by
geography and loan type. It is available as an interactive
tool
that can be tailored to showcase trends by category, including
amortization type, lien position, loan purpose, property and transaction
types, and can provide state- and market-specific comparisons of
mortgage loan defect levels.

April 2019 Loan Application Defect Index

  • The frequency of defects, fraudulence and misrepresentation in the
    information submitted in mortgage loan applications decreased by 4.2
    percent compared with the previous month.
  • Compared to April 2018, the Defect Index increased by 11.0 percent.
  • The Defect Index is down 10.8 percent from the high point of risk in
    October 2013.
  • The Defect Index for refinance transactions decreased by 3.5 percent
    compared with previous month, and is up 16.9 percent compared with a
    year ago.
  • The Defect Index for purchase transactions decreased by 4.0 percent
    compared with the previous month, and is up 10.3 percent compared with
    a year ago.

Chief Economist Analysis: Lower Mortgage Rates Help Break Defect Risk
Trend

“The frequency of defects, fraudulence and misrepresentation in the
information submitted in mortgage loan applications declined 4.2 percent
compared to last month. Notably, this marks the first month-over-month
decline since July 2018, thanks to lower mortgage rates,” said Mark
Fleming, chief economist at First American. “Decreasing mortgage rates
contributed to an increase in inventory, reducing the competitive
pressure on the housing market, as well as contributing to an increase
in lower-risk refinance transactions. In line with this trend, the Loan
Application Defect Index
for purchase transactions declined for the
first time in eight months, falling 4.0 percent in April compared with
the previous month.

“The two competing trends that resulted in a flat fraud risk last month
were the increasing share of less risky refinance transactions working
to decrease overall fraud risk, and the continuation of the hot sellers’
market, motivating buyers to misrepresent information in order to
qualify for a bigger mortgage and increase overall fraud risk,” said
Fleming.

“The mix of refinance and purchase activity fluctuated within the month
of April. Refinance
activity increased
in the first half of the month as mortgage rates
declined. However, lower mortgage rates also fueled an increase in
purchase transactions, as buyers took advantage of their increased
house-buying power,” said Fleming. “In fact, purchase
applications hit their highest level in nine years
towards the end
of April. While loan application defects can happen on both purchase or
refinance transactions, there is a higher propensity for fraud and
misrepresentation with purchase transactions.

Increased Inventory Cools Misrepresentation Pressure

“However, the decline in mortgage rates had a third and even more
important consequence, which was to help alleviate some of the supply
constraints that made the housing market so competitive,” said Fleming.
“As we saw in last
month’s report
, in extremely competitive markets, there is more
motivation to misrepresent information on a loan application to qualify
for the bigger mortgage in order to win the bidding war.

“Most recently, real estate agents indicate that their buyers
are encouraged by an unexpected surge of supply
. April did see an increase
in total housing inventory
, rising to 1.83 million from 1.67 million
in March, which is a 1.7% increase year-over-year. Potential buyers feel
less inclined to misrepresent information on a loan application when
they don’t feel the pressure of a hot sellers’ market. Indeed,
misrepresentation of income and employment both fell this month, by 1.7
percent and 3.6 percent respectively,” said Fleming.

“The future of fraud and misrepresentation risk is tied closely to
mortgage rates. Increased inventory reduces competitive pressures and
misrepresentation risk, alongside the rising share of lower-risk
refinance transactions,” said Fleming. “It remains to be seen if
mortgage rates, now flirting with 4 percent, will go any lower. If so,
we may anticipate the continued downward trend in defect risk and
misrepresentation, with further increases in refinance transactions and
inventory, resulting in less pressure on the market.”

April 2019 State Highlights

  • The five states with a year-over-year increase in defect frequency
    are: New York (+37.3 percent), Nebraska (+37.0 percent), Iowa (+35.0
    percent), Hawaii (+33.7 percent), and West Virginia (+31.1 percent).
  • There are two states with the year-over-year decrease in defect
    frequency: Arkansas (-4.8 percent) and Florida (-1.1 percent).

April 2019 Local Market Highlights

  • Among the largest 50 Core Based Statistical Areas (CBSAs), the five
    markets with the greatest year-over-year increase in defect frequency
    are: Buffalo, N.Y. (+36.9 percent), Pittsburgh (+31.3 percent),
    Richmond, Va. (+30.1 percent), Cincinnati (+29.3 percent), and New
    York (+26.3 percent).
  • Among the largest 50 Core Based Statistical Areas (CBSAs), the five
    markets with year-over-year decrease in defect frequency are:
    Jacksonville, Fla. (-11.6 percent), Houston (-8.5 percent), Orlando,
    Fla. (-7.4 percent), San Diego (-4.3 percent), and Miami (-2.0
    percent).

Next Release

The next release of the First American Loan Application Defect Index
will take place the week of June 24, 2019.

Methodology

The methodology statement for the First American Loan Application Defect
Index is available at http://www.firstam.com/economics/defect-index.

Disclaimer

Opinions, estimates, forecasts and other views contained in this page
are those of First American’s chief economist, do not necessarily
represent the views of First American or its management, should not be
construed as indicating First American’s business prospects or expected
results, and are subject to change without notice. Although the First
American Economics team attempts to provide reliable, useful
information, it does not guarantee that the information is accurate,
current or suitable for any particular purpose. © 2019 by First
American. Information from this page may be used with proper attribution.

About First American

First American Financial Corporation (NYSE: FAF) is a leading
provider of title insurance, settlement services and risk solutions for
real estate transactions that traces its heritage back to 1889. First
American also provides title plant management services; title and other
real property records and images; valuation products and services; home
warranty products; property and casualty insurance; banking, trust and
wealth management services; and other related products and services.
With total revenue of $5.7 billion in 2018, the company offers its
products and services directly and through its agents throughout the
United States and abroad. In 2019, First American was named to the Fortune 100
Best Companies to Work For® list for the fourth consecutive
year. More information about the company can be found at www.firstam.com.

Contacts

Marcus Ginnaty
Corporate Communications
First American
Financial Corporation
(714) 250-3298


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect

Published

on

Continue Reading

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania